📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Phase 2 Trial of Topical Application of the Hedgehog Inhibitor Patidegib in Patients With Gorlin Syndrome. (2024)

First Author: Lear JT

Attributed to: Defining the role of the IgE-Fc epsilon receptor-1 immune surveillance axis in human cutaneous squamous cell carcinoma funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1093/bjd/ljae444

PubMed Identifier: 39545486

Publication URI: http://europepmc.org/abstract/MED/39545486

Type: Journal Article/Review

Parent Publication: The British journal of dermatology

ISSN: 0007-0963